HSHHSH Health Technology Supplier Hub
Home › Suppliers › Boston Scientific › Risk

Boston Scientific: risk summary

Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.

Financial

Latest full-year results from official filings.

FY2025 revenue $20.07bn (+19.9%); operating margin 18.0%; net income $2.90bn.

Balance sheet figures not captured from release.

Researched 8 Nov 2026

Adverse media

Credible news about incidents, disputes, legal action or restructuring in the last 24 months.

Aug–Sep 2026: a cyberattack forced Boston Scientific to shut plants and distribution centres globally; the company said it would likely miss its Q3 and full-year 2026 sales and earnings guidance, after two earlier guidance cuts that year.

Researched 10 Nov 2026

Cyber & information governance

Data breaches, cyber incidents, regulator action and assurance status.

Aug 2026: Boston Scientific disclosed to the SEC a cyberattack (detected 25 Aug) that disrupted order processing, manufacturing and shipping worldwide; it reported full restoration in Sep and said it found no evidence of compromise to its products. NHS DSPT status not yet checked.

Researched 10 Nov 2026

Regulatory & clinical safety

Recalls, safety notices, regulator action and clinical safety concerns.

2026: FDA classed two Boston Scientific recalls as most serious: AXIOS stent delivery systems (Feb 2026; 167 serious injuries, 3 deaths reported) and unused Infinion CX spinal cord stimulator leads (Jun 2026 letter; 1,081 serious injuries, no deaths).

Researched 10 Nov 2026

Contract performance

Contract delivery, go-lives, terminations and disputes.

Aug–Sep 2026: the cyberattack interrupted supply to hospitals; the CEO said many areas lacked adequate supply, some procedures were lost and some hospitals likely ordered from other suppliers before full restoration.

Researched 10 Nov 2026